英文别名 |
1-(2-hydroxyethyl)-8-[5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy)anilino]-4,5-dihydropyrazolo[4,3-h]quinazoline-3-carboxamide;CHEBI:1217805;NMS-P937;1-(2-Hydroxyethyl)-8-[[5-(4-Methylpiperazin-1-Yl)-2-(Trifluoromethoxy)phenyl]amino]-4,5-Dihydropyrimido[5,4-G]indazole-3-Carboxamide;CHEMBL1738758;SureCN1228019;1-(2-hydroxy-ethyl)-8-[5-(4-methyl-piperazin-1-yl)-2-trifluoromethoxy-phenylamino]-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide;UNII-67RM91WDHQ;AMX10197;1-(2-hydroxyethyl)-8-[5-(4-methylpiperazin-1-yl)-2-trifluoromethoxyphenylamino]-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide;1H-Pyrazolo(4,3-H)quinazoline-3-carboxamide, 4,5-dihydro-1-(2-hydroxyethyl)-8-((5-(4-methyl-1-piperazinyl)-2-(trifluoromethoxy)phenyl)amino)-;NMS-P937 (NMS1286937);1-(2-hydroxyethyl)-8-[5-(4-methylpiperazin-1-yl)-2-trifluoromethoxyphenylamino]-4,5-;NMS P937;NMS1286937;NMS-1286937;NMS-1286937,NMS-P937;4,5-Dihydro-1-(2-hydroxyethyl)-8-[[5-(4-methyl-1-piperazinyl)-2-(trifluoromethoxy)phenyl]amino]-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide;Onvansertib;Onvansertib free base;67RM91WDHQ;Onvansertib (USAN);Onvansertib [USAN];NMS 1286937;1-(2-Hydroxyethyl)-8-((5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy)phenyl)amino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide;1-(2-hydroxyethyl)-8-[5-(4-;1-(2-Hydroxyethyl)-8-((5-(4-methylpip;HMS3673E21;MFCD26793840;1H-Pyrazolo[4,3-h]quinazoline-3-carboxamide, 4,5-dihydro-1-(2-hydroxyethyl)-8-[[5-(4-methyl-1-piperazinyl)-2-(trifluoromethoxy)phenyl]amino]-;1H-Pyrazolo[4,3-h]quinazoline-3-carboxamide, 4,5-dihydro-1-(2-hydroxyethyl)-8-[[5-(4-methyl-1-piperazinyl)-2-(trifluoromethoxy)phenyl]amino]-;Q27087959;GLXC-15790;HY-15828;1-(2-HYDROXYETHYL)-8-((5-(4-METHYLPIPERAZIN-1-YL)-2-(TRIFLUOROMETHOXY)PHENYL)AMINO)-4,5-DIHYDRO-1H-PYRAZOLO(4,3-H)QUINAZOLINE-3-CARBOXAMIDE;NSC800806;SY311879;AKOS027253333;WHO 11172;1-(2-hydroxyethyl)-8-(5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy)phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide;NMS-P937 (NMS1286937)?;s7255;CS-3146;CCG-269924;SB16941;1-(2-hydroxyethyl)-8-{[5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy)phenyl]amino}-1H,4H,5H-pyrazolo[4,3-h]quinazoline-3-carboxamide;BDBM50343559;NSC781344;NCGC00386361-03;MS-29838;AC-36303;D11458;1-(2-hydroxyethyl)-8-(5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy)anilino)-4,5-dihydropyrazolo(4,3-h)quinazoline-3-carboxamide;1-(2-hydroxyethyl)-8-{[5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy)phenyl]amino}-4H,5H-pyrazolo[4,3-h]quinazoline-3-carboxamide;ONVANSERTIB [INN];HMS3653G04;NMS-P 937;PCM-075;PCM-075;NMS-1286937;NMS-P937;BCP28066;NSC-800806;1034616-18-6;SW219402-1;GTPL7918;1-(2-Hydroxyethyl)-8-[[5-(4-methyl-1-piperazinyl)-2-(trifluoromethoxy)phenyl]amino]-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide;DB15110;NSC-781344;POLO-LIKE KINASE 1 INHIBITOR NMS-1286937;EX-A1590;DTXSID70102... |